Supplementary Table S9 from Integration of Whole-Genome Sequencing Analysis with Unique Patient-Derived Models Reveals Clinically Relevant Drug Targets in TFCP2 Fusion–Defined Rhabdomyosarcoma
收藏数据链接：
官方服务：
资源简介：
Supplementary Table S9 shows differential expression analysis comparing TFCP2-rearranged RMS (including IORMS-01) to other RMS subtypes.
创建时间：
2025-12-02
